Short Effects of a Rehabilitation Session on Gait in Patients With CNS
NCT ID: NCT01807247
Last Updated: 2015-02-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2013-02-28
2014-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. muscle strengthening of the lower limbs and
2. effort reconditioning with cyclo ergometer, on gait characteristics (kinematics, kinetics and electromyographic) in patients with central nervous system lesion.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Gait Rehabilitation With Motor Imagery in People With Parkinson's Disease
NCT04788693
Efficacy of a Mechanical Gait Repetitive Training Technique in Hemiparetic Stroke Patients (AVC)
NCT00284115
Optimize Motor Learning to Improve Neurorehabilitation
NCT04759976
Evolution of Walking Abilities in Subacute Stroke Patients Hospitalized in Neurorehabilitation Center
NCT06327035
Impact of Prolonged Physical Therapy on Gait Performance of Chronic Phase Stroke Patients
NCT00658710
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hemiparetic
Intensive lower limbs muscles strengthening
Intensive lower limbs muscles strengthening
Spinal cord injury
Intensive lower limbs muscles strengthening
Intensive lower limbs muscles strengthening
Multiple sclerosis
Intensive lower limbs muscles strengthening
Intensive lower limbs muscles strengthening
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intensive lower limbs muscles strengthening
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hemiplegia after stroke or paraplegia incomplete ASIA C or D or multiple sclerosis (EPSS \<5).
* Walking with or without technical assistance
* Patients who received and signed information and informed consent
* Patient who received physiotherapy session for rehabilitation of the lower limbs
* Patients able to perform the entire study
Exclusion Criteria
* Pregnant women, breastfeeding
* Patient who has received botulinum toxin injection of in the lower limbs between 3 weeks and 2 months prior to inclusion in the study
* Bilateral Brain damage, cerebellar syndrome, apraxia, severe aphasia
* Orthopedic complications preventing walking
* Patients who participated in a clinical study within 3 months prior to inclusion • No affiliation to a social security scheme (beneficiary or assignee)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre d'Investigation Clinique et Technologique 805
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nicolas ROCHE
MDPHD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nicolas ROCHE, MDPHD
Role: PRINCIPAL_INVESTIGATOR
Hôpital RAYMOND POINCARE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital Raymond Poincare
Garches, Garches, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-A01487-34
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.